Below update was posted on the EudraCT What’s New section, on October 01, 2020:
Sponsors of trials that are “prematurely ended” can now post results in EudraCT as a pdf document.
- For trials that were approved but never started, sponsors are required to state the reasons for the premature interruption in the pdf document
- For trials that started and terminated early, sponsors are required to state the reasons for the early interruption, together with any partial result, if available, in the pdf document
Please refer to the Tutorials on posting results in order to know how to become a primary user for your trial and post the pdf document. After the document has been uploaded, kindly click on “post results” on the top right corner. The document will be published in EU CTR after 2 weeks from posting date (except for phase 1 trials in adults, that are not publicly available, see FAQs).